Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
3-{3-[4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-yl]-ureido}-propionic acid ethyl ester → 3-[3-(4-Methyl-5-pyridin-4-yl-thiazol-2-yl)-ureido]-propionic acid ethyl ester
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 3-{3-[4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-yl]-ureido}-propionic acid ethyl ester | HCID 11247129 | — |
| 반응물 | [3-(4-Methyl-5-pyridin-4-yl-thiazol-2-yl)-ureido]-acetic acid ethyl ester | HCID 11415948 | — |
| 생성물 | 3-[3-(4-Methyl-5-pyridin-4-yl-thiazol-2-yl)-ureido]-propionic acid ethyl ester | HCID 11416363 | — |
반응 단계
This compound is prepared by an analogous procedure to 3-{3-[4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-yl]-ureido}-propionic acid ethyl ester (Example 14) by replacing 4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-ylamine hydrobromide (13b) with 4-methyl-5-pyridin-4-yl-thiazol-2-ylamine (see Example 16 for reference).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08404684B2 |
| 출처 데이터셋 | uspto-grants-2013_03 |
| ORD ID | ord-db1c140c7b3346bd82afd42fa84d251a |
| 출처 메모 | uspto-grants-2013_03 |